Oncology News | pharmaphorum

News

FDA approves Keytruda in cervical cancer

Merck & Co’s blockbuster Keytruda has been approved in advanced second line cervical cancer, becoming the first drug in its class approved in the indication.

News

AstraZeneca and Lilly’s Alzheimer’s drug fails trial

The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial results.

News

Scotland's NHS to fund Ipsen cancer diarrhoea drug

Decision welcomed as step forward for patients

News

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

AstraZeneca has widened the licence for its cancer drug Tagrisso (osimertinib) in Europe after regulators gave it the green-light for first-line use against additional types of non-small ce

News

Lung cancer drug Keytruda to become routinely available on N...

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.

News

Amgen faces first Neulasta biosimilar rival as FDA approves ...

Amgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar version of the blockbuster cancer infection biologic.

FDA approves Keytruda in cervical cancer

AstraZeneca and Lilly’s Alzheimer’s drug fails trial

Scotland's NHS to fund Ipsen cancer diarrhoea drug

AZ’s Tagrisso wins new NSCLC first-line approval in Europe

Lung cancer drug Keytruda to become routinely available on N...

Amgen faces first Neulasta biosimilar rival as FDA approves ...

AZ boosts vaccine capabilities with Omniose buy

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks